Boulevard Expands Clinical Capabilities for Medspas with Launch of ePrescribe

Boulevard (www.joinblvd.com), provider of the business management platform trusted by the fastest-growing salons, spas, and medspas, today announced the launch of ePrescribe, a new feature that brings...

Autore: Business Wire

New integration with ScriptSure enables seamless e-prescribing directly from patient profiles

LOS ANGELES: Boulevard (www.joinblvd.com), provider of the business management platform trusted by the fastest-growing salons, spas, and medspas, today announced the launch of ePrescribe, a new feature that brings secure electronic prescribing directly into patient profiles. ePrescribe enables medspas and other clinical wellness practices to manage prescriptions alongside scheduling, charting, payments, and the broader patient experience within the Boulevard platform, eliminating system switching, reducing duplicate data entry, and minimizing risk of error.

Powered through a partnership with D.A.W. Systems (dawsystems.com) and its ScriptSure e-prescribing solution, Boulevard ePrescribe is designed to support protocol-driven care, repeat visits, and collaborative wellness teams that require both speed and precision.

“Medspas shouldn’t have to stitch together separate systems just to deliver great care,” said Matt Danna, co-founder and CEO of Boulevard. “We built Boulevard to create a seamless experience for patients and providers alike, but prescribing has been one of the last workflows pushing teams outside that system. With ePrescribe, it finally lives in the same place, giving care teams a connected workflow inside the patient record and a better experience from consult to follow-up.”

Integration with ScriptSure means Boulevard’s customers gain direct access to the industry’s leading e-prescribing solution, one used by more than 30,000 licensed prescribers nationwide. By partnering with ScriptSure, Boulevard enables clinicians and practitioners to initiate prescriptions, select medications and directions, review automated safety alerts, and send prescriptions to the pharmacy, all from the same patient profile they already use to manage clinical charting, photo markups, treatment documentation, and purchase history.

“D.A.W. Systems is proud to partner with Boulevard, the industry’s leading medspa software platform,” said John Ketcham, CRO, D.A.W. Systems. “This integration brings together the two tools that top-performing medspas already rely on, giving providers a fully unified workflow from booking to prescribing and setting a new standard for what great medspa technology looks like.”

Designed for Modern Medspas

Most establishments in the fast-growing medspa industry provide medical-grade treatments-from IV therapy and hormone optimization to GLP-1s and other prescription-based services-but have historically needed separate EMRs or standalone e-prescribing systems to manage medications. This forced teams to manually re-enter patient information across platforms, creating operational inefficiencies and compliance risk. Now, with Boulevard ePrescribe, prescriptions, purchases, and paperwork live together in one place.

Boulevard ePrescribe supports controlled, non-controlled, and compounded medications. Built to the highest EPCS and HIPAA compliance standards, Boulevard supports identity verification and multi-factor authentication. Other key capabilities include:

Boulevard ePrescribe is available now. To learn more, visit www.joinblvd.com/features/prescriptions.

About Boulevard

Boulevard offers the business management platform trusted by the fastest-growing salons, spas, and medspas. Boulevard empowers business owners and professionals alike to deliver personable, enjoyable experiences to their clients through online appointment scheduling, messaging, marketing, and payments that are simple, elegant, and reliable. Founded in 2016, Boulevard has earned the trust of thousands of businesses across the nation by delivering the world-class technology and genuine service they deserve. To learn more, visit joinblvd.com.

Fonte: Business Wire


Visualizza la versione completa sul sito

Informativa
Questo sito o gli strumenti terzi da questo utilizzati si avvalgono di cookie necessari al funzionamento ed utili alle finalità illustrate nella cookie policy. Se vuoi saperne di più o negare il consenso a tutti o ad alcuni cookie, consulta la cookie policy. Chiudendo questo banner, acconsenti all’uso dei cookie.